Overview

Biocompatible 3D Printing Materials Market is poised to register a CAGR of 22% during the forecast period 2022 to 2028.

In the biocompatible 3D printing materials industry, three-dimensional (3D) and four-dimensional (4D) printing is emerging as a trend for the construction of complex structures. High accuracy and layer-by-layer incorporation of intelligent materials is opening the way for stakeholders and manufacturers to create dynamic 3D structures.

Similarly, 3D and 4D printing are becoming more popular in the creation of scaffolds used in tissue engineering. Furthermore, biocompatible 3D printing technology is being employed more and more for tissue regeneration in magneto-responsive polymers and vascular tissue engineering applications. As a result, stakeholders and companies in the biocompatible 3D printing materials market employ the technology to create patient-specific biomedical equipment. Using this technology, manufacturers in the biocompatible 3D printing materials market create 3D-printed tubular scaffolds containing nanofibers for bone applications. 3D printing aids in the creation of bone scaffolds and gives great extensibility in the handling of biodegradable, biocompatible, and biocomposite polymeric materials. As a result, high magnification micrographs of 3D tubular scaffolds show a smooth homogeneous surface morphology following polymer layer deposition.

Biomaterial inks are increasingly being employed in the biocompatible 3D printing materials industry to create hard scaffolds for the permanent or slow-degrading stability of a cell structure. Bioinks, on the other hand, aid in the production of softer scaffolds that can be quickly replaced by the entrenched cell population's deposition of extracellular matrix (ECM). Similarly, producers are creating bioinks with the help of hydrogels that serve as a better medium for 3D cell culturing. Furthermore, bioinks created with hydrogels are biocompatible and easily compatible with the physical, mechanical, and biological features of 3D cell formations.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Biocompatible 3D Printing Materials Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Biocompatible 3D Printing Materials Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Biocompatible 3D Printing Materials Market:
• 3D Systems, Inc.
• Stratasys Ltd.
• Evonik Industries AG
• Renishaw plc
• Formlabs Inc.
• Envisiontec, Inc.
• Sandvik AB
• Elix Polymers SLU
• Concept Laser GmbH
• Apium Additive Technologies GmbH
• EOS GmbH
• Aspect Biosystems Ltd.
• Cemetrix Solutions
• Bioink Solution, Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Biocompatible 3D Printing Materials Market Segmentation:
By Product
• Polymers
 o Polylactic Acid (PLA)
 o Acrylonitrile Butadiene Styrene (ABS)
 o Polypropulenes
 o Polyamides
 o Polycarbonates
 o Photopolymers
 o Others
• Metal
 o Titanium
 o Stainless Steel
 o Others
• Others (Ceramics and Composites)
By Form
• Powder
• Liquid
• Others
By Application
• Implants & Prostheses
• Prototyping & Surgical Guides
• Tissue Engineering
• Hearing Aids
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Biocompatible 3D Printing Materials Market Video Sample:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Biocompatible 3D Printing Materials Market By Product, By Form, By Application and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Biocompatible 3D Printing Materials Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Biocompatible 3D Printing Materials Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Biocompatible 3D Printing Materials Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Biocompatible 3D Printing Materials Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Polymers
       7.1.1. Polylactic Acid (PLA)
       7.1.2. Acrylonitrile Butadiene Styrene (ABS)
       7.1.3. Polypropulenes
       7.1.4. Polyamides
       7.1.5. Polycarbonates
       7.1.6. Photopolymers
       7.1.7. Others
  7.2. Metal
       7.2.1. Titanium
       7.2.2. Stainless Steel
       7.2.3. Others
  7.3. Others (Ceramics and Composites)

8. Biocompatible 3D Printing Materials Market, By Form Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Powder
  8.2. Liquid
  8.3. Others

9. Biocompatible 3D Printing Materials Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. Implants & Prostheses
  9.2. Prototyping & Surgical Guides
  9.3. Tissue Engineering
  9.4. Hearing Aids
  9.5. Others

10. North America Biocompatible 3D Printing Materials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Biocompatible 3D Printing Materials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Biocompatible 3D Printing Materials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Biocompatible 3D Printing Materials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   16.1. 3D Systems, Inc.
         16.1.1. Company Overview
         16.1.2. Product Portfolio
         16.1.3. SWOT Analysis
         16.1.4. Financial Overview
         16.1.5. Strategic Overview
   16.2. Stratasys Ltd.
         16.2.1. Company Overview
         16.2.2. Product Portfolio
         16.2.3. SWOT Analysis
         16.2.4. Financial Overview
         16.2.5. Strategic Overview
   16.3. Evonik Industries AG
         16.3.1. Company Overview
         16.3.2. Product Portfolio
         16.3.3. SWOT Analysis
         16.3.4. Financial Overview
         16.3.5. Strategic Overview
   16.4. Renishaw plc
         16.4.1. Company Overview
         16.4.2. Product Portfolio
         16.4.3. SWOT Analysis
         16.4.4. Financial Overview
         16.4.5. Strategic Overview
   16.5. Formlabs Inc.
         16.5.1. Company Overview
         16.5.2. Product Portfolio
         16.5.3. SWOT Analysis
         16.5.4. Financial Overview
         16.5.5. Strategic Overview          
   16.6. Envisiontec, Inc.
         16.6.1. Company Overview
         16.6.2. Product Portfolio
         16.6.3. SWOT Analysis
         16.6.4. Financial Overview
         16.6.5. Strategic Overview      
   16.7. Sandvik AB
         16.7.1. Company Overview
         16.7.2. Product Portfolio
         16.7.3. SWOT Analysis
         16.7.4. Financial Overview
         16.7.5. Strategic Overview
   16.8. Elix Polymers SLU
         16.8.1. Company Overview
         16.8.2. Product Portfolio
         16.8.3. SWOT Analysis
         16.8.4. Financial Overview
         16.8.5. Strategic Overview
   16.9. Concept Laser GmbH
         16.9.1. Company Overview
         16.9.2. Product Portfolio
         16.9.3. SWOT Analysis
         16.9.4. Financial Overview
         16.9.5. Strategic Overview
   16.10.Apium Additive Technologies GmbH
         16.10.1. Company Overview
         16.10.2. Product Portfolio
         16.10.3. SWOT Analysis
         16.10.4. Financial Overview
         16.10.5. Strategic Overview
   16.11.EOS GmbH
         16.11.1. Company Overview
         16.11.2. Product Portfolio
         16.11.3. SWOT Analysis
         16.11.4. Financial Overview
         16.11.5. Strategic Overview      
   16.12.Aspect Biosystems Ltd.
         16.12.1. Company Overview
         16.12.2. Product Portfolio
         16.12.3. SWOT Analysis
         16.12.4. Financial Overview
         16.12.5. Strategic Overview
   16.13.Cemetrix Solutions
         16.13.1. Company Overview
         16.13.2. Product Portfolio
         16.13.3. SWOT Analysis
         16.13.4. Financial Overview
         16.13.5. Strategic Overview
   16.14.Bioink Solution, Inc.
         16.14.1. Company Overview
         16.14.2. Product Portfolio
         16.14.3. SWOT Analysis
         16.14.4. Financial Overview
         16.14.5. Strategic Overview

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the regulations initiated by healthcare administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures